| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.0000163843.70369.12 |
| P698 | PubMed publication ID | 15790931 |
| P50 | author | Brendan M. McQuillan | Q43818574 |
| John Beilby | Q56457353 | ||
| Caroline L Chapman | Q57571057 | ||
| P2093 | author name string | Joseph Hung | |
| Peter L Thompson | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | interleukins | Q194908 |
| obesity | Q12174 | ||
| metabolic syndrome | Q657193 | ||
| insulin resistance | Q1053470 | ||
| P304 | page(s) | 1268-1273 | |
| P577 | publication date | 2005-03-24 | |
| P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
| P1476 | title | Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance | |
| P478 | volume | 25 |
| Q35941368 | A Study to Investigate the Efficacy and Safety of an Anti-Interleukin-18 Monoclonal Antibody in the Treatment of Type 2 Diabetes Mellitus |
| Q33926100 | Adipocytokines and the metabolic syndrome among older persons with and without obesity: the InCHIANTI study |
| Q46685753 | Adult subjects with Prader-Willi syndrome show more low-grade systemic inflammation than matched obese subjects |
| Q47139364 | Are IL18RAP gene polymorphisms associated with body mass regulation? A cross-sectional study |
| Q26993207 | Assessment of cardiometabolic risk in children in population studies: underpinning developmental origins of health and disease mother-offspring cohort studies |
| Q36287002 | Association of interleukin-18 gene polymorphism with body mass index in women |
| Q46678880 | Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study |
| Q36381096 | Biomarkers of obesity and subsequent cardiovascular events |
| Q33401964 | Body mass index and acute kidney injury in the acute respiratory distress syndrome |
| Q38187337 | Caspases and inflammasomes in metabolic inflammation |
| Q37943057 | Cholesterol, cytokines and diseases. |
| Q37136196 | Circulating IL-18 and the risk of type 2 diabetes in women |
| Q46769718 | Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity. |
| Q34573680 | Circulating interleukin-18: A specific biomarker for atherosclerosis-prone patients with metabolic syndrome |
| Q35808941 | Circulating levels of IL-18 are significantly influenced by the IL-18 +183 A/G polymorphism in coronary artery disease patients with diabetes type 2 and the metabolic syndrome: an observational study |
| Q44126035 | Clinical Significance of Serum IL-6 and TNF-α Levels in Patients with Metabolic Syndrome |
| Q47745560 | Correlation between plasma, synovial fluid and articular cartilage Interleukin-18 with radiographic severity in 33 patients with osteoarthritis of the knee |
| Q62125043 | Cross-sectional correlates of increased IL-18 but reduced fetuin-A and oxytocin with adiposity and blood indices in metabolic syndrome patients with and without prediabetes |
| Q36617125 | Cytokines in type 2 diabetes. |
| Q46021155 | Depressive symptoms and metabolic syndrome: selective association in older women. |
| Q38294300 | Diet, behavior and immunity across the lifespan. |
| Q26785013 | Does the sympathetic nervous system contribute to the pathophysiology of metabolic syndrome? |
| Q47247555 | Effect of the Mediterranean diet with and without weight loss on markers of inflammation in men with metabolic syndrome |
| Q39954667 | Effects of gender on serum biomarkers of systemic inflammation coincident to experimentally-induced periapical lesions |
| Q36880195 | Effects of lifestyle interventions on inflammatory markers in the metabolic syndrome |
| Q51480962 | Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus. |
| Q51498308 | Elevation of plasma interleukin-18 concentration is associated with insulin levels in patients with systemic lupus erythematosus. |
| Q37306273 | Epidemiology of cytokines: the Women On the Move through Activity and Nutrition (WOMAN) Study |
| Q91748968 | Epigenetic Age Acceleration in Adolescence Associates With BMI, Inflammation, and Risk Score for Middle Age Cardiovascular Disease |
| Q33731942 | Evaluation and integration of 49 genome-wide experiments and the prediction of previously unknown obesity-related genes |
| Q45918376 | Felodipine downregulates serum interleukin-18 levels in rats with fructose-induced metabolic syndrome. |
| Q36671813 | Felodipine reduces cardiac expression of IL-18 and perivascular fibrosis in fructose-fed rats |
| Q59798515 | Frequency of metabolic syndrome and associated factors in institutionalized elderly individuals |
| Q54778831 | Gain-of-function SNPs in NLRP3 and IL1B genes confer protection against obesity and T2D: undiscovered role of inflammasome genetics in metabolic homeostasis? |
| Q43778070 | Gene-PUFA interactions and obesity risk |
| Q34023565 | Genetic polymorphisms of cytokine genes in type 2 diabetes mellitus |
| Q35172378 | Genetic variation within IL18 is associated with insulin levels, insulin resistance and postprandial measures |
| Q35638692 | High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors |
| Q52582325 | IL-1 Family Cytokine Pathways Underlying NAFLD: Towards New Treatment Strategies. |
| Q46558389 | Impact of inflammatory markers on cardiovascular mortality in patients with metabolic syndrome |
| Q38784122 | Increased adipose tissue expression of IL-18R and its ligand IL-18 associates with inflammation and insulin resistance in obesity. |
| Q35044541 | Increased expression of IL-18 in the serum and islets of type 1 diabetics |
| Q83979184 | Increased serum interleukin-18 concentration is associated with hypoadiponectinemia in obesity, independently of insulin resistance |
| Q38034273 | Inflammation links excess fat to insulin resistance: the role of the interleukin-1 family |
| Q35838041 | Inflammatory and oxidative stress responses to high-carbohydrate and high-fat meals in healthy humans |
| Q42686418 | Inflammatory biomarkers CRP, MCP-1, serum amyloid alpha and interleukin-18 in patients with HTN and dyslipidemia: impact of diabetes mellitus on metabolic syndrome and the effect of statin therapy |
| Q37350491 | Influence of gestational overfeeding on myocardial proinflammatory mediators in fetal sheep heart |
| Q51321723 | Insulin resistance, metabolic syndrome and chronic low grade inflammation in Sheehan's syndrome on standard replacement therapy: a case control study. |
| Q57416312 | Inter-relationships of interleukin-6, cardiovascular risk factors and the metabolic syndrome among older men |
| Q34723169 | Interaction of osteopontin with IL-18 in obese individuals: implications for insulin resistance. |
| Q47424568 | Interleukin-18 and testosterone levels in men with metabolic syndrome. |
| Q35865066 | Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency |
| Q42817301 | Interleukin-18 enhances glucose uptake in 3T3-L1 adipocytes |
| Q37105230 | Interleukin-18 is a strong predictor of cardiovascular events in elderly men with the metabolic syndrome: synergistic effect of inflammation and hyperglycemia |
| Q34450892 | Interleukin-18 null mutation increases weight and food intake and reduces energy expenditure and lipid substrate utilization in high-fat diet fed mice |
| Q38685111 | Interleukin-18 polymorphism as an inflammatory index in metabolic syndrome: A preliminary study. |
| Q81681379 | Interleukin-18 resistance in patients with obesity and type 2 diabetes mellitus |
| Q50021277 | Interleukin-18 serum level is elevated in type 2 diabetes and latent autoimmune diabetes. |
| Q38295214 | Interleukin-18 suppresses adiponectin expression in 3T3-L1 adipocytes via a novel signal transduction pathway involving ERK1/2-dependent NFATc4 phosphorylation |
| Q28118491 | Interleukin-18/WNT1-inducible signaling pathway protein-1 signaling mediates human saphenous vein smooth muscle cell proliferation |
| Q47285927 | Interleukin-18: Biological properties and role in disease pathogenesis |
| Q60472237 | Interleukin-6 is a better metabolic biomarker than interleukin-18 in young healthy adults |
| Q33552112 | Joint association of obesity and metabolic syndrome with incident mobility limitation in older men and women--results from the Health, Aging, and Body Composition Study |
| Q33855479 | Lean body mass, interleukin 18, and metabolic syndrome in apparently healthy Chinese |
| Q47335964 | Levels of circulating cortisol and cytokines in members of the Canadian Armed Forces: Associations with age, sex and anthropometry |
| Q37430665 | Maternal nutrient restriction during early fetal kidney development attenuates the renal innate inflammatory response in obese young adult offspring. |
| Q36032785 | Metabolic syndrome and osteoporotic fracture: a population-based study in China |
| Q36691127 | Metabolic syndrome influences cardiac gene expression pattern at the transcript level in male ZDF rats |
| Q60959905 | NLRP3 Inflammasome: A Possible Link Between Obesity-Associated Low-Grade Chronic Inflammation and Colorectal Cancer Development |
| Q28571405 | Overexpression of interleukin-18 aggravates cardiac fibrosis and diastolic dysfunction in fructose-fed rats |
| Q54260312 | Oxidative Stress and NLRP3-Inflammasome Activity as Significant Drivers of Diabetic Cardiovascular Complications: Therapeutic Implications. |
| Q37104395 | Oxidative protein damage is associated with elevated serum interleukin-6 levels among older moderately to severely disabled women living in the community |
| Q41675413 | Per os colchicine administration in cholesterol fed rabbits: Triglycerides lowering effects without affecting atherosclerosis progress |
| Q51197845 | Peripheral fibrinolytic markers, soluble adhesion molecules, inflammatory cytokines and endothelial function in hypopituitary adults with growth hormone deficiency. |
| Q51486562 | Plasma levels of interleukin-6 and C-reactive protein are associated with physical inactivity independent of obesity. |
| Q34238563 | Plasma soluble gp130 levels are increased in older subjects with metabolic syndrome. The role of insulin resistance. |
| Q37296393 | Potential role of interleukin-18 in patients with rheumatoid arthritis-associated carotid intima-media thickness but not insulin resistance |
| Q37212046 | Reduced circulating adiponectin levels are associated with the metabolic syndrome independently of obesity, lipid indices and serum insulin levels: a cross-sectional study |
| Q58692657 | Regulation of Energy Expenditure and Brown/Beige Thermogenic Activity by Interleukins: New Roles for Old Actors |
| Q39342382 | Role of the Immune System in Hypertension |
| Q51498830 | The effect of abdominal obesity on insulin sensitivity and serum lipid and cytokine concentrations in African women. |
| Q33569142 | The metabolic syndrome |
| Q37398576 | The role of interleukin 18 in the pathogenesis of hypertension-induced vascular disease |
| Q33804391 | The role of interleukin-18 in the metabolic syndrome |
| Q42407082 | The ubiquitous interleukin-6: a time for reappraisal |
| Q57398619 | Utility of the metabolic syndrome and its components in the prediction of incident cardiovascular disease: a prospective cohort study |
| Q46044501 | Vascular biomarkers in the metabolic syndrome |
| Q42853651 | −607 C/A polymorphism in the promoter of IL-18 gene is associated with 2 h post-loading plasma glucose level in Chinese |
Search more.